Business Continuity and Risk Mitigation in the Pharmaceutical Industry: Strengthening Supply Chains for Pandemic Preparedness

The article highlights the vulnerabilities in pharmaceutical supply chains exposed by the COVID-19 pandemic and emphasizes the need for robust business continuity and risk management strategies to ensure the uninterrupted supply of essential medical products. It identifies key challenges such as raw material sourcing, production constraints, regulatory hurdles, and distribution delays. To address these, the article suggests enhancing supply chains through diversified supplier networks, real-time tracking with AI and blockchain, stockpiling strategies, and flexible manufacturing protocols. It also underscores the importance of public-private partnerships and collaboration with regulatory bodies to improve industry preparedness for future pandemics.